CUI JINGRONG JEAN (Chief Scientific Officer) sold 4.0% of their position (41.50K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.45M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−7.10K
Price / share
$55.43
Trade value
$393.55K
% of position
Common Stock
Shares
−3.80K
Price / share
$56.17
Trade value
$213.45K
% of position
Common Stock
Shares
−600.00
Price / share
$56.95
Trade value
$34.17K
% of position
Common Stock
Shares
−600.00
Price / share
$55.45
Trade value
$33.27K
% of position
Common Stock
Shares
−2K
Price / share
$56.84
Trade value
$113.68K
% of position
Common Stock
Shares
−1.30K
Price / share
$57.59
Trade value
$74.87K
% of position
Common Stock
Shares
−5K
Price / share
$58.75
Trade value
$293.75K
% of position
Common Stock
Shares
−2.40K
Price / share
$59.76
Trade value
$143.42K
% of position
Common Stock
Shares
−200.00
Price / share
$60.43
Trade value
$12.09K
% of position
Common Stock
Shares
−3.60K
Price / share
$60.30
Trade value
$217.08K
% of position
Common Stock
Shares
−8.10K
Price / share
$61.13
Trade value
$495.15K
% of position
Common Stock
Shares
−6.50K
Price / share
$62.05
Trade value
$403.01K
% of position
Common Stock
Shares
−305.00
Price / share
$62.71
Trade value
$19.13K
% of position
Net shares
−41.50K
Net value
-$2.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/13/2019 | S · Sale | −7.10K | $55.43 | $393.55K | 0.7% | 1.03M | 1.02M |
| Common Stock Indirect | 12/13/2019 | S · Sale | −3.80K | $56.17 | $213.45K | 0.4% | 1.02M | 1.02M |
| Common Stock Indirect | 12/13/2019 | S · Sale | −600.00 | $56.95 | $34.17K | 0.1% | 1.02M | 1.01M |
| Common Stock Indirect | 12/16/2019 | S · Sale | −600.00 | $55.45 | $33.27K | 0.1% | 1.01M | 1.01M |
| Common Stock Indirect | 12/16/2019 | S · Sale | −2K | $56.84 | $113.68K | 0.2% | 1.01M | 1.01M |
| Common Stock Indirect | 12/16/2019 | S · Sale | −1.30K | $57.59 | $74.87K | 0.1% | 1.01M | 1.01M |
| Common Stock Indirect | 12/16/2019 | S · Sale | −5K | $58.75 | $293.75K | 0.5% | 1.01M | 1.01M |
| Common Stock Indirect | 12/16/2019 | S · Sale | −2.40K | $59.76 | $143.42K | 0.2% | 1.01M | 1M |
| Common Stock Indirect | 12/16/2019 | S · Sale | −200.00 | $60.43 | $12.09K | 0.0% | 1M | 1M |
| Common Stock Indirect | 12/17/2019 | S · Sale | −3.60K | $60.30 | $217.08K | 0.4% | 1M | 999.62K |
| Common Stock Indirect | 12/17/2019 | S · Sale | −8.10K | $61.13 | $495.15K | 0.8% | 999.62K | 991.52K |
| Common Stock Indirect | 12/17/2019 | S · Sale | −6.50K | $62.05 | $403.01K | 0.7% | 991.52K | 985.02K |
| Common Stock Indirect | 12/17/2019 | S · Sale | −305.00 | $62.71 | $19.13K | 0.0% | 985.02K | 984.72K |
| Total | −41.50K | -$2.45M | ||||||
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.30M | Direct |
| Total | 1.30M | 1.30M direct |